Three abstracts will be presented during the annual San Antonio Breast Cancer Symposium (SABCS) taking place December 9-12, 2025, in San Antonio, TX.
News
- PreciseDxR Presents New Data for PreciseBreastR, an AI Digital Pathology Test to Predict ...
- bioAffinity Technologies' Noninvasive CyPath® Lung Test to Be Highlighted at American ... - Nasdaq
SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive ...
- Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of ...
These findings, presented at the 2025 San Antonio Breast Cancer Symposium (SABCS), confirm that the Deciparticle™technology represents a ...
- Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
... San Antonio Breast Cancer Symposium (SABCS) from December 9-12, 2025 ... Biotechnology · Computer ...
- Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio ...
(Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium (SABCS), in San Antonio, TX ...